Marianne Ivarsson

Title: The Innovative Contributions of Marianne Ivarsson

Introduction

Marianne Ivarsson is a notable inventor based in Lund, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit human neutrophil elastase. With a total of 2 patents, her work is crucial in addressing diseases where neutrophil elastase activity plays a detrimental role.

Latest Patents

Ivarsson's latest patents focus on 2-pyrazinone derivatives that are designed for the treatment of diseases or conditions where the inhibition of neutrophil elastase activity is beneficial. The inventions provide compounds of a specific formula, including optical isomers, racemates, tautomers, and pharmaceutically acceptable salts. These compounds are essential as they serve as inhibitors of human neutrophil elastase, offering potential therapeutic benefits.

Career Highlights

Marianne Ivarsson is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to contribute to innovative solutions in healthcare, particularly in the development of new therapeutic agents.

Collaborations

Ivarsson has collaborated with esteemed colleagues such as Hans Lönn and Peter Hansen. These partnerships have enhanced her research and development efforts, leading to advancements in her field.

Conclusion

Marianne Ivarsson's contributions to pharmaceutical innovations highlight her role as a key inventor in the industry. Her patents and collaborative efforts continue to pave the way for new treatments that can significantly impact patient care.